Dr. Reddy's Laboratories Limited: all 249 studies

Page 2 of 3. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed ConditionCompletedNCT01674517Phase 1
• Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting ConditionCompletedNCT01674504Phase 1
• Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting ConditionsCompletedNCT01673997Phase 1
• Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed ConditionCompletedNCT01671722Phase 1
• Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting ConditionCompletedNCT01671709Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01645449Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01645423Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01645410Phase 1
• Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting ConditionsCompletedNCT01645384Phase 1
• Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting ConditionCompletedNCT01627886Phase 1
• Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed ConditionCompletedNCT01627847Phase 1
• Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting ConditionCompletedNCT01627834Phase 1
• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed ConditionsCompletedNCT01621763Phase 1
• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting ConditionsCompletedNCT01621750Phase 1
• Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01581879Phase 1
• Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting ConditionsCompletedNCT01581866Phase 1
• Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed ConditionsCompletedNCT01581788Phase 1
• Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01581775Phase 1
• Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting ConditionCompletedNCT01566487Phase 1
• A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile ColitisCompletedNCT01559545Phase 2
• Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting ConditionCompletedNCT01513720Phase 1
• Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed ConditionCompletedNCT01513681Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed ConditionsCompletedNCT01513057Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting ConditionsCompletedNCT01513044Phase 1
• Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed ConditionsCompletedNCT01512485Phase 1
• Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed ConditionsCompletedNCT01512459Phase 1
• Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting ConditionsCompletedNCT01511770Phase 1
• Bioavailability Study of Fluconazole Tablets 200 mg Under Fed ConditionsCompletedNCT01511757Phase 1
• Bioavailability Study of Famotidine Tablets 40 mg Under Fasting ConditionsCompletedNCT01511731Phase 1
• Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed ConditionCompletedNCT01511718Phase 1
• Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting ConditionCompletedNCT01511705Phase 1
• Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed ConditionsCompletedNCT01506791Phase 1
• Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506713Phase 1
• Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506076Phase 1
• Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01506063Phase 1
• Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting ConditionCompletedNCT01506050Phase 1
• Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed ConditionCompletedNCT01506037Phase 1
• Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506011Phase 1
• Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed ConditionsCompletedNCT01505998Phase 1
• Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed ConditionCompletedNCT01504516Phase 1
• Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting ConditionCompletedNCT01504503Phase 1
• Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionCompletedNCT01503450Phase 1
• Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting ConditionCompletedNCT01503437Phase 1
• Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyCompletedNCT01503424Phase 1
• Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01503398Phase 1
• Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01375452Phase 1
• Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting ConditionsCompletedNCT01373138Phase 1
• Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01372982Phase 1
• Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting ConditionsCompletedNCT01372358Phase 1
• Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting ConditionsCompletedNCT01372345Phase 1
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fed ConditionCompletedNCT01372306Phase 1
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting ConditionCompletedNCT01372280Phase 1
• Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed ConditionsCompletedNCT01314352Phase 1
• Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.CompletedNCT01314339Phase 1
• Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01286701Phase 1
• Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01286688Phase 1
• Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01283932Phase 1
• Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283919Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting ConditionsCompletedNCT01283867Phase 1
• Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01283841Phase 1
• Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283061Phase 1
• Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting ConditionsCompletedNCT01270308Phase 1
• Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed ConditionsCompletedNCT01269281Phase 1
• Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting ConditionsCompletedNCT01267396Phase 1
• Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed ConditionsCompletedNCT01267383Phase 1
• Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting ConditionsCompletedNCT01264302Phase 1
• Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting ConditionsCompletedNCT01264289Phase 1
• Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the ToenailsTerminatedNCT01208168Phase 3
• Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the ToenailsTerminatedNCT01208129Phase 3
• Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed ConditionCompletedNCT01170182Phase 1
• Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting ConditionsCompletedNCT01170169Phase 1
• Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01167933Phase 1
• Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting ConditionCompletedNCT01167894Phase 1
• Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting ConditionCompletedNCT01166100Phase 1
• Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01166087Phase 1
• Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed ConditionsCompletedNCT01164826Phase 1
• Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting ConditionsCompletedNCT01164813Phase 1
• Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed ConditionsCompletedNCT01164800Phase 1
• Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting ConditionsCompletedNCT01164787Phase 1
• Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting ConditionsCompletedNCT01164774Phase 1
• Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01164761Phase 1
• Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01161979Phase 1
• Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01161966Phase 1
• Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01161940Phase 1
• Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting ConditionsCompletedNCT01161927Phase 1
• Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01161147Phase 1
• Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01161134Phase 1
• Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01160068Phase 1
• Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01160042Phase 1
• Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01160029Phase 1
• Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01159158Phase 1
• Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01155960Phase 1
• Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01155947Phase 1
• Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01155934Phase 1
• Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01155921Phase 1
• Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) ConditionsCompletedNCT01155908Phase 1
• Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting ConditionsCompletedNCT01155895Phase 1
• Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01149980Phase 1
• Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01149967Phase 1
• Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01149954Phase 1

← Dr. Reddy's Laboratories Limited overview and focus areas